Search - tctmd.com

Displaying 1 - 20 of 89

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

Presenter: Stephane Noble

October 26, 2025

Presentation TCT 2025

How I Treat A Failed Evolut

Presenter: Adnan K. Chhatriwalla

October 26, 2025

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

AS in Women

Presenter: Renuka Jain

October 29, 2024

Presentation TCT 2024

Procedural Considerations

Presenter: Kendra Grubb

October 29, 2024

Presentation TCT 2024

Case Background and Valve Selection Discussion

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

Case Outcome

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

SMART Data

Presenter: Howard Herrmann

October 29, 2024

Presentation TCT 2024

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

Presenter: Alexandre Abizaid

October 29, 2024

Presentation TCT 2024

Evolution of PCI – Role and Value of Drug-Eluting Balloons

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Presenter: Anthony Matta

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

Presenter: Steven Yakubov

October 25, 2023

Presentation TCT 2023

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

Presenter: Guilherme Attizzani

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Advertisement

TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent

How I Treat A Failed Evolut

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

AS in Women

Procedural Considerations

Case Background and Valve Selection Discussion

Case Outcome

SMART Data

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

Evolution of PCI – Role and Value of Drug-Eluting Balloons

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content